Table 7.
The expression of leptin and leptin receptor in patients with different molecular breast cancer subtypes.
| Group | n (%) | Leptin | P value | Leptin receptor | P value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| − | + | ++ | +++ | − | + | ++ | +++ | ||||
| HR+ | 123 | 41 (33.3) | 34 (27.6) | 44 (35.8) | 4 (3.3) | <0.001 | 22 (17.9) | 26 (21.1) | 53 (43.1) | 22 (17.9) | 0.001 |
| HER2+ | 136 | 28 (20.6) | 30 (22.1) | 51 (37.5) | 27 (19.9) | 13 (9.6) | 23 (16.9) | 49 (36.0) | 51 (37.5) | ||
| Triple negative | 66 | 12 (18.2) | 14 (21.2) | 26 (39.4) | 14 (21.2) | 7 (10.6) | 5 (7.6) | 31 (47.0) | 23 (34.8) | ||
HR+ – hormone receptor positive; HER2+ – human epidermal growth factor receptor 2 positive.